Launched on February 5, 2001, the iShares Biotechnology ETF (IBB) is a passively managed exchange traded fund designed to ...
Biotechnology is a broad discipline in which biological processes, organisms, cells or cellular components are exploited to develop new technologies. New tools and products developed by ...
The National Security Commission on Emerging Biotechnology visited UW–Madison to discuss Wisconsin’s biohealth strengths, ...
(Nasdaq: VIR), today announced the appointment of Suzanne Topalian, M.D., to its Board of Directors, effective October 27, ...
Vir Biotechnology (VIR) has signed a collaboration and license agreement with Gilead focused on three PRO-XTEN dual-masked ...
In this column, the author discusses how food biotechnology is evolving from scientific innovation into a scalable ...
Vir Biotechnology is approaching multiple clinical readouts from drugs with positive data previously. Click here to read an ...
Mycology reveals fungi's potential in mycoremediation, sustainable construction, and psilocybin research, addressing key ...
Subcutaneous administration is designed to widen the therapeutic window and extend FL115’s potential across a broad range of ...
The Treasury Department is proposing rules to add biotechnology to its Outbound Investment Security Program under the COINS Act. The U.S. Department of the Treasury issued a Notice of Proposed ...
Nautilus Biotechnology, Inc. reported its financial results for the third quarter ended September 30, 2026. Revenue was $0.2 million for the third quarter of 2026, primarily driven by grant revenue ...
The Treasury Department’s proposed restrictions on U.S. investment in Chinese biopharma collide with Beijing’s new export ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results